TEN Switch - An Observational Phase IV Study to Evaluate the Safety and Efficacy of Substituting Tenofovir for Didanosine in Virologically Controlled HIV-Infected Patients Co-Infected With Hepatitis C Virus.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms TEN-Switch
- 20 Oct 2009 Biomarkers information updated
- 20 Oct 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 20 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.